Novel small-molecule therapy of Hodgkin lymphoma

被引：8
|
作者：
Buglio, D. [1 ]
Georgakis, G. [1 ]
Younes, A. [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2007年 / 7卷 / 05期
关键词：
Bcl-2; bortezomib; HDAC; HSP90; mTOR; Reed-Sternberg;
D O I：
10.1586/14737140.7.5.735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The treatment of Hodgkin lymphoma continues to be based on combination chemotherapy and radiation therapy. Although this treatment strategy produces a high cure rate, short- and long-term toxic effects continue to be problematic for young cured patients. In this review we focus on emerging novel therapies using small molecules that target specific survival pathways in the cancer cells. This approach is aimed at improving the cure rate while reducing treatment-related toxicity.
引用
收藏
页码：735 / 740
页数：6
相关论文
共 50 条
  • [41] Advances in small-molecule therapy for managing angina pectoris in the elderly
    Waheed, Nida
    Mahmoud, Ahmad
    Rambarat, Cecil A.
    Pepine, Carl J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (12) : 1471 - 1481
  • [42] The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
    Han, Hai-Hao
    Wang, Han-Min
    Jangili, Paramesh
    Li, Mingle
    Wu, Luling
    Zang, Yi
    Sedgwick, Adam C.
    Li, Jia
    He, Xiao-Peng
    James, Tony D.
    Kim, Jong Seung
    CHEMICAL SOCIETY REVIEWS, 2023, 52 (03) : 879 - 920
  • [43] Establishing the principle of reversibility in peptide/protein and small-molecule therapy
    Shechter, Yoram
    Sasson, Keren
    Marcus, Yonit
    Rubinraut, Sara
    Lev-Goldman, Vered
    Fridkin, Mati
    THERAPEUTIC DELIVERY, 2012, 3 (01) : 17 - 23
  • [44] The Novel Multitarget Small-Molecule Inhibitor SRX3177 Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma
    Pal, Dhananjaya
    McHale, Cody C.
    Benrashid, Samon
    Gourabathini, Poornima
    Maddeboina, Krishnaiah
    Vann, Kendra R.
    Mani, Rajeswaran
    Kutateladze, Tatiana
    Martin, Peter
    Di Liberto, Maurizio
    Chen-Kiang, Selina
    Park, Steven I.
    Durden, Donald L.
    BLOOD, 2021, 138
  • [45] Small-molecule compounds target paraptosis to improve cancer therapy
    Wang, Yujia
    Wen, Xiang
    Zhang, Nan
    Wang, Lian
    Hao, Dan
    Jiang, Xian
    He, Gu
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [46] Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
    Xiao, Wenjing
    Zhou, Qiaodan
    Wen, Xudong
    Wang, Rui
    Liu, Ruijie
    Wang, Tingting
    Shi, Jianyou
    Hu, Yonghe
    Hou, Jun
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [47] MASTL small-molecule inhibition to target mitosis for cancer therapy
    Toledo, Chad M.
    Eisele, Koleen J.
    Kim, Dong Hyun
    Mu, Xinmeng
    Brun, Sonja
    Davis, Carl
    Greenwald, Eric C.
    Hui, Fion
    He, Meilan
    Yang, Yanling
    Flores-Bojorquez, Ana
    Li, Yuxin
    Khamphavong, Penney L.
    Lee, Joseph H.
    Li, Jian
    Ramms, Dana J.
    Jones, Greg
    Auth, Marin
    Painter, Cory L.
    Nager, Andrew
    Oyer, Jon
    Timofeevski, Sergei L.
    Pierceall, William E.
    Murtaza, Anwar
    Heyen, Jonathan R.
    Gallego, Rebecca
    Quinlan, Casey
    McAlpine, Indrawan
    VanArsdale, Todd L.
    CANCER RESEARCH, 2024, 84 (06)
  • [48] Clinically approved representative small-molecule drugs for cardiopathy therapy
    Ma, Shaowei
    Jiang, Min
    Wang, Xiao
    Li, Bin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 283
  • [49] Breaking down KRAS: small-molecule degraders for cancer therapy
    Kos, Tina
    Saur, Dieter
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [50] A novel small-molecule inhibitor of HIV-1 entry
    Heredia, Alonso
    Latinovic, Olga S.
    Barbault, Florent
    de Leeuw, Erik P. H.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5469 - 5478
12345